https://ct99021inhibitor.com/m....edical-diagnosis-and
Patient case data are part of the current data set from the ongoing phase I clinical trial (NCT04820023). In a study of BBT-176's inhibitory effect, the half-maximal inhibitory concentration (IC5 values were found to be 436, 179, and 535 nmol/L against EGFR 19Del/C797S, EGFR 19Del/T790M/C797S, and EGFR L858R/C797S, respectively. Osimertinib levels were quantified at 30439, 12482, and 57372 nmol/L. The inhibitory concentration 50 (IC5 values of BBT-176 against Ba/F3 cells
כמו
תגובה
לַחֲלוֹק
